Skip to content
lifestyle.cfxmagazine.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Mezzion Pharmaceuticals, Inc
Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients
May 22, 2026
Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD
May 21, 2026
Mezzion Pharmaceuticals Applauds Give Kids a Chance Act Becoming Law
February 11, 2026
Mezzion Pharmaceuticals Appoints Physician-Scientist Ridwan Shabsigh, MD, FACS as President & Chief Operating Officer
January 6, 2026
Mezzion Announces U.S. Patent Allowance Strengthening Udenafil Exclusivity in Fontan Patients
December 4, 2025